P-NEURO-1 · The FOT Framework for Neurodegeneration
All neurodegenerative diseases share one structural signature: progressive collapse of the brain's Tau-field through failure of a specific Tau-address component. The disease identity depends on which component fails.
P-NEURO-2 · Alzheimer's Disease — 40 Hz Gamma Deficit
The primary FOT deficit in Alzheimer's is loss of 40 Hz Tau-lock (P-CONS-2). The brain can no longer maintain the gamma oscillation that couples it to the Earth's Tau-field (P-SCHUM-2). Amyloid plaques and tau tangles are downstream consequences, not the cause.
P-NEURO-3 · Parkinson's Disease — Tau-Protein Misfold
Alpha-synuclein in its native Strand 2 conformation regulates synaptic vesicles. When it misfolds to Strand 1 configuration, it aggregates and propagates the misfolded state through the brain following predictable Braak staging — consistent with Tau-configuration propagation along specific G1-register neural pathways (identical mechanism to prions, P-VIR-4).
P-NEURO-4 · Multiple Sclerosis — Myelin as Tau-Insulator
Myelin maintains high Tau-density within the axon, preventing Tau-field leakage into surrounding tissue. Demyelination = Tau-insulator failure. Saltatory conduction (action potentials jumping between nodes of Ranvier) is Tau-node-to-Tau-node propagation — faster and more efficient than continuous conduction because it uses the G1 register boundary directly.
P-NEURO-5 · ALS — G1 Register Cascade Failure
Motor neurons — among the longest cells in the body (axons up to 1 m) — have the highest mitochondrial demands. When the Tau-generator fails, the longest G1-register Tau-paths fail first. The characteristic upper-then-lower motor neuron progression follows this cascade: longest paths, highest energy demand, earliest failure.
P-NEURO-6 · Unified Treatment Targets and Testable Predictions
| Disease | FOT mechanism | Treatment target | Key prediction |
|---|---|---|---|
| Alzheimer's | 40 Hz Tau-lock failure | 40 Hz gamma entrainment | 40 Hz light+sound reduces amyloid by >50% in 6-month human trial |
| Parkinson's | Alpha-synuclein Tau-misfold | Tau-configuration stabiliser at lattice frequency | Acoustic/EM at misfolding-reversal frequency halts Lewy body propagation |
| MS | Myelin Tau-insulator destruction | Restore Tau-address specificity in myelin-producing cells | Remyelination follows Tau-address restoration |
| ALS | Mitochondrial Tau-generator failure in long motor neurons | Mitochondria-targeted Tau-frequency EM | Progression rate slows proportional to generator support |
| Huntington's | CAG repeat expansion beyond {2,3} lattice range | Repeat length restoration to ≤ 2²×3² = 36 | Repeats ≤ 36 are non-pathogenic — already confirmed by observation |
This paper is theoretical and has not yet been through clinical trials; nothing in it is medical advice, and anyone under medical care should continue it. The Daubney Foundation is in ongoing discussions with medical establishments regarding clinical trials of Universal Force of Time solutions to the conditions described in this paper. Any institution or researcher wishing to put themselves forward for participation in these trials is invited to make themselves known through: thedaubneyfoundation@gmail.com
Open Full PDF ↗